| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |